Issn Print: 0022-1899
Publication Date: 2017/06/15
Suppressor Cell–Depleting Immunotherapy With Denileukin Diftitox is an Effective Host-Directed Therapy for Tuberculosis
Shashank Gupta; Laurene Cheung; Supriya Pokkali; Kathryn Winglee; Haidan Guo; John R. Murphy; William R Bishai
Author Information: Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, Maryland; and
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.